New Zealand markets closed

Medifast, Inc. (MED)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
18.90+0.13 (+0.69%)
At close: 04:00PM EDT
19.22 +0.32 (+1.69%)
After hours: 06:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 206.72M
Enterprise value 62.31M
Trailing P/E 7.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.27
Price/book (mrq)1.01
Enterprise value/revenue 0.08
Enterprise value/EBITDA 1.32

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-76.50%
S&P500 52-week change 326.33%
52-week high 383.60
52-week low 317.73
50-day moving average 319.28
200-day moving average 336.23

Share statistics

Avg vol (3-month) 3437.5k
Avg vol (10-day) 3199.2k
Shares outstanding 510.94M
Implied shares outstanding 610.94M
Float 89.44M
% held by insiders 12.55%
% held by institutions 197.90%
Shares short (30 Aug 2024) 42.07M
Short ratio (30 Aug 2024) 46.43
Short % of float (30 Aug 2024) 428.80%
Short % of shares outstanding (30 Aug 2024) 418.95%
Shares short (prior month 31 Jul 2024) 42.76M

Dividends & splits

Forward annual dividend rate 46.6
Forward annual dividend yield 434.92%
Trailing annual dividend rate 31.65
Trailing annual dividend yield 38.79%
5-year average dividend yield 45.49
Payout ratio 461.57%
Dividend date 307 Nov 2023
Ex-dividend date 418 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 3.81%
Operating margin (ttm)-4.67%

Management effectiveness

Return on assets (ttm)6.99%
Return on equity (ttm)15.01%

Income statement

Revenue (ttm)770.18M
Revenue per share (ttm)70.61
Quarterly revenue growth (yoy)-43.10%
Gross profit (ttm)N/A
EBITDA 47.34M
Net income avi to common (ttm)29.33M
Diluted EPS (ttm)2.68
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)163.5M
Total cash per share (mrq)15.35
Total debt (mrq)19.1M
Total debt/equity (mrq)9.30%
Current ratio (mrq)2.98
Book value per share (mrq)19.27

Cash flow statement

Operating cash flow (ttm)60.8M
Levered free cash flow (ttm)18.05M